ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.

Quote:

Search for Ticker

Free Membership

Search:

ESRX: Express Scripts Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

EXPRESS SCRIPTS INC (NASD)
ESRX	88.19	0.24	(0.27%)	Vol. 2,069,334	16:00 ET

Express Scripts, Inc. is one of the largest pharmacy benefit management companies in North America. Through facilities in the states and Canada, the company serves thousands of client groups, including managed care organizations, insurance carriers, third-party administrators, employers and union-sponsored benefit plans.

General Information

EXPRESS SCRIPTS

One Express Way St. Louis, MO 63121 Phone: 314 996-0900 Fax: 314 770-0303 Web: www.express-scripts.com Email: investor.relations@express-scripts.com

Industry	MED-WHSL DRG/SN
Sector:	Retail/Wholesale

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/24/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	87.95
52 Week High	88.58
52 Week Low	42.75
Beta	0.92
20 Day Moving Average	2,561,150.50
Target Price Consensus	91.71

% Price Change
4 Week	5.44
12 Week	17.20
YTD	54.76

% Price Change Relative to S&P 500
4 Week	4.30
12 Week	10.50
YTD	28.09

Share Information
Shares Outstanding (millions)	274.42
Market Capitalization (millions)	23,349.97
Short Ratio	3.60
Last Split Date	06/25/2007

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.90
Current Year EPS Consensus Estimate	3.48
Estimated Long-Term EPS Growth Rate	17.30
Next EPS Report Date	02/24/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.30
30 Days Ago	1.22
60 Days Ago	1.24
90 Days Ago	1.24

Fundamental Ratios

P/E
Current FY Estimate:	24.47
Trailing 12 Months:	25.17
PEG Ratio	1.41

EPS Growth
vs. Previous Year	0.00%
vs. Previous Quarter	-7.95%

Sales Growth
vs. Previous Year	3.10%
vs. Previous Quarter:	2.11%

Price Ratios
Price/Book	7.06
Price/Cash Flow	24.00
Price / Sales	1.06

ROE
09/30/09	39.83
06/30/09	53.86
03/31/09	84.59

ROA
09/30/09	11.18
06/30/09	12.95
03/31/09	15.16

Current Ratio
09/30/09	2.21
06/30/09	2.21
03/31/09	0.79

Quick Ratio
09/30/09	2.15
06/30/09	2.15
03/31/09	0.72

Operating Margin
09/30/09	3.96
06/30/09	3.89
03/31/09	3.88

Net Margin
09/30/09	5.78
06/30/09	5.84
03/31/09	6.05

Pre-Tax Margin
09/30/09	5.78
06/30/09	5.84
03/31/09	6.05

Book Value
09/30/09	12.05
06/30/09	11.37
03/31/09	5.25

Inventory Turnover
09/30/09	114.91
06/30/09	118.56
03/31/09	116.57

Debt-to-Equity
09/30/09	1.05
06/30/09	1.13
03/31/09	0.89

Debt to Capital
09/30/09	51.22
06/30/09	52.96
03/31/09	47.16


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research